Series A funding round for Beacon Biosignals raising $27M in November 2021
Series A funding round for Beacon Biosignals raising $27M in November 2021
| Investor | Firm Type | Partner |
|---|
General CatalystLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Troy Carter | |
| Angel | Andrew Beck |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$116M
Top Valuation
-
Beacon Biosignals raised $27M in a Series A round.
The round was announced on 11/01/21.
The round was led by General Catalyst.